Robert E. Kates

3.8k total citations
92 papers, 3.0k citations indexed

About

Robert E. Kates is a scholar working on Cardiology and Cardiovascular Medicine, Analytical Chemistry and Pharmacology. According to data from OpenAlex, Robert E. Kates has authored 92 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Cardiology and Cardiovascular Medicine, 37 papers in Analytical Chemistry and 19 papers in Pharmacology. Recurrent topics in Robert E. Kates's work include Cardiac electrophysiology and arrhythmias (53 papers), Analytical Methods in Pharmaceuticals (37 papers) and Antibiotics Pharmacokinetics and Efficacy (18 papers). Robert E. Kates is often cited by papers focused on Cardiac electrophysiology and arrhythmias (53 papers), Analytical Methods in Pharmaceuticals (37 papers) and Antibiotics Pharmacokinetics and Efficacy (18 papers). Robert E. Kates collaborates with scholars based in United States, Italy and Brazil. Robert E. Kates's co-authors include Sandra R. Harapat, Donald C. Harrison, Roberto Latini, Roger A. Winkle, Deborah Keefe, Stuart J. Connolly, Carl V. Leier, Gianni Tognoni, Yin‐Gail Yee and Anne M. Gillis and has published in prestigious journals such as Circulation, Annals of the New York Academy of Sciences and CHEST Journal.

In The Last Decade

Robert E. Kates

92 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Kates United States 33 1.8k 590 493 336 297 92 3.0k
R. G. McAllister United States 30 1.0k 0.6× 358 0.6× 252 0.5× 249 0.7× 319 1.1× 68 2.5k
B Beermann Sweden 27 561 0.3× 403 0.7× 247 0.5× 388 1.2× 243 0.8× 98 2.4k
PA Routledge United Kingdom 28 788 0.4× 308 0.5× 122 0.2× 298 0.9× 374 1.3× 107 2.4k
Dennis E. Drayer United States 29 474 0.3× 554 0.9× 260 0.5× 309 0.9× 142 0.5× 64 2.5k
G. G. Belz Germany 26 1.2k 0.7× 452 0.8× 171 0.3× 168 0.5× 261 0.9× 116 2.1k
Patrice Jaillon France 38 2.3k 1.3× 855 1.4× 241 0.5× 524 1.6× 509 1.7× 171 5.2k
M. J. Kendall United Kingdom 29 497 0.3× 214 0.4× 280 0.6× 401 1.2× 254 0.9× 127 2.4k
Thorir D. Bjornsson United States 28 538 0.3× 466 0.8× 148 0.3× 295 0.9× 278 0.9× 72 2.8k
C G Regårdh Sweden 28 506 0.3× 438 0.7× 370 0.8× 468 1.4× 307 1.0× 59 2.8k
David Lalka United States 23 267 0.2× 339 0.6× 250 0.5× 364 1.1× 230 0.8× 71 1.8k

Countries citing papers authored by Robert E. Kates

Since Specialization
Citations

This map shows the geographic impact of Robert E. Kates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Kates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Kates more than expected).

Fields of papers citing papers by Robert E. Kates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Kates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Kates. The network helps show where Robert E. Kates may publish in the future.

Co-authorship network of co-authors of Robert E. Kates

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Kates. A scholar is included among the top collaborators of Robert E. Kates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Kates. Robert E. Kates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haas, David W., Benjamin Johnson, Paul Spearman, et al.. (2000). Evidence of a Source of HIV Type 1 within the Central Nervous System by Ultraintensive Sampling of Cerebrospinal Fluid and Plasma. AIDS Research and Human Retroviruses. 16(15). 1491–1502. 43 indexed citations
2.
Jung, Donald, Albert Dorr, Robert Raschke, et al.. (1998). Effect of High‐Dose Oral Ganciclovir on Didanosine Disposition in Human Immunodeficiency Virus (HIV)‐Positive Patients. The Journal of Clinical Pharmacology. 38(11). 1057–1062. 15 indexed citations
3.
Ruder, Michael A., Cynthia Lebsack, Roger A. Winkle, et al.. (1991). Disposition Kinetics of Orally Administered Enoximone in Patients with Moderate to Severe Heart Failure. The Journal of Clinical Pharmacology. 31(8). 702–708. 4 indexed citations
4.
Winkle, Roger A., Nellis A. Smith, Michael A. Ruder, et al.. (1990). Pharmacodynamics of enoximone during intravenous infusion. International Journal of Cardiology. 28. S1–S2. 2 indexed citations
5.
Liem, L. Bing, et al.. (1988). Pharmacodynamics of Procainamide in Patients With Ventricular Tachyarrhythmias. The Journal of Clinical Pharmacology. 28(11). 984–989. 4 indexed citations
6.
Babany, G, et al.. (1988). Evaluation of the in vivo dose-response relationship of immunosuppressive drugs using a mouse heart transplant model: application to cyclosporine.. Journal of Pharmacology and Experimental Therapeutics. 244(1). 259–262. 24 indexed citations
7.
Gillis, Anne M. & Robert E. Kates. (1986). Myocardial uptake kinetics and pharmacodynamics of propafenone in the isolated perfused rabbit heart.. Journal of Pharmacology and Experimental Therapeutics. 237(3). 708–712. 28 indexed citations
8.
Kates, Robert E., et al.. (1985). Metabolite cumulation during chronic propafenone dosing in arrhythmia. Clinical Pharmacology & Therapeutics. 37(6). 610–614. 51 indexed citations
9.
Lee, John Tayu, Jean‐Marc Davy, & Robert E. Kates. (1985). Evaluation of Combined Administration of Verapamil and Disopyramide in Dogs. Journal of Cardiovascular Pharmacology. 7(3). 501–507. 4 indexed citations
10.
Kates, Robert E., Deborah Keefe, & Roger A. Winkle. (1983). Lorcainide disposition kinetics in arrhythmia patients. Clinical Pharmacology & Therapeutics. 33(1). 28–34. 19 indexed citations
11.
Kates, Robert E.. (1983). Plasma level monitoring of antiarrhythmic drugs. The American Journal of Cardiology. 52(6). C8–C13. 14 indexed citations
12.
Maze, Mervyn, et al.. (1983). Verapamil Decreases MAC for Halothane in Dogs. Anesthesiology. 59(4). 327–329. 20 indexed citations
13.
Keefe, Deborah & Robert E. Kates. (1982). Myocardial disposition and cardiac pharmacodynamics of verapamil in the dog.. Journal of Pharmacology and Experimental Therapeutics. 220(1). 91–96. 40 indexed citations
14.
Harapat, Sandra R. & Robert E. Kates. (1982). High-performance liquid chromatographic analysis of propafenone in human plasma samples. Journal of Chromatography B Biomedical Sciences and Applications. 230(2). 448–453. 47 indexed citations
15.
Keefe, Deborah, Sandra R. Harapat, & Robert E. Kates. (1981). Relationship between pharmacodynamics and myocardial concentration of verapamil. The American Journal of Cardiology. 47. 406–406. 7 indexed citations
16.
Jaillon, Patrice, et al.. (1981). Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure. American Heart Journal. 101(5). 534–540. 27 indexed citations
17.
Yee, Yin‐Gail & Robert E. Kates. (1981). High-performance liquid chromatographic analysis of lorcainide and its active metabolite, norlorcainide, in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 223(2). 454–459. 11 indexed citations
18.
Kates, Robert E., Theodore D. Sokoloski, & Thomas J. Comstock. (1978). Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias. Clinical Pharmacology & Therapeutics. 23(1). 30–35. 18 indexed citations
19.
Kates, Robert E., et al.. (1977). Rapid GLC Determination of Propranolol in Human Plasma Samples. Journal of Pharmaceutical Sciences. 66(10). 1490–1492. 19 indexed citations
20.
Kates, Robert E., et al.. (1976). Increased methotrexate toxicity due to concurrent probenecid administration. Biochemical Pharmacology. 25(13). 1485–1488. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. G. McAllister Breakdown of academic impact, for papers by B Beermann Breakdown of academic impact, for papers by PA Routledge Breakdown of academic impact, for papers by Dennis E. Drayer Breakdown of academic impact, for papers by G. G. Belz Breakdown of academic impact, for papers by Patrice Jaillon Breakdown of academic impact, for papers by M. J. Kendall Breakdown of academic impact, for papers by Thorir D. Bjornsson Breakdown of academic impact, for papers by C G Regårdh Breakdown of academic impact, for papers by David Lalka
Rankless by CCL
2026